Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GRAIL, Inc.

Get SEC filing alerts via email and in your feed for GRAIL, Inc.

GRAL

GRAIL, Inc.

About GRAIL, Inc.

GRAIL, Inc. develops multi-cancer early detection (MCED) blood tests, primarily through its Galleri platform, to identify over 50 cancer types at early stages. Its products aim to complement existing screening guidelines, improve early diagnosis, and reduce cancer mortality. The company leverages proprietary methylation technology, extensive clinical data, and strategic partnerships to expand access, gain regulatory approval, and establish a new standard in population-wide cancer screening.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from GRAIL, Inc.

1
1
GRAIL, Inc. GRAIL Reports $40.8 Million Revenue in Q1 2026, Driven by 37% Increase in Screening Revenue

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
GRAIL, Inc. GRAIL, Inc. Reports 17% Revenue Growth and Improved Net Loss in Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
GRAIL, Inc. GRAIL Reports 26% Revenue Growth to $36.2 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
GRAIL, Inc. GRAIL Reports $35.5 Million Revenue in Q2 2025, Net Loss Reduced to $114 Million

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
GRAIL, Inc. GRAIL Reports $31.8 Million Revenue in Q1 2025, Driven by 24% Increase in Screening Revenue

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
GRAIL, Inc. GRAIL Reports $2.027 Billion Net Loss and 35% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
GRAIL, Inc. GRAIL Reports 38% Revenue Growth, Net Loss of $125.7M in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments